Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Arthritis, Psoriatic 3Adenomatous Polyposis Coli 1

Interventions

guselkumab 3tofacitinib 1sonelokimab 1risankizumab 1cabozantinib 1Vaccines 1Specimen Handling 1Saline Solution 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Infliximab 1Herpes Zoster Vaccine 1Etanercept 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Arthritis, Psoriatic × guselkumab × Clear all
NCT04936308 2026-06-05

SOLSTICE

Janssen Research & Development, LLC

Phase 3 Active not recruiting
453 enrolled 25 charts

Arthritis, Psoriatic

NCT03796858 2025-02-03

COSMOS

Janssen Pharmaceutica N.V., Belgium

Phase 3 Completed
285 enrolled

Arthritis, Psoriatic

NCT03162796 2021-02-03

Discover-1

Janssen Research & Development, LLC

Phase 3 Completed
383 enrolled 106 charts

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡